William Naber, MD
General Practice · San Francisco, CANPI 1912093626
Payments from drug & device makers
Across 283 payments — averaging $32.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$2K
- AbbVie$1K
- Boehringer Ingelheim$799
- Amarin Pharma, Inc.$626
- AstraZeneca$611
- Novo Nordisk$563
- plus $4K from 24 others
What the payments were for
- Food & beverage$9,143100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 52 | $1,674 |
| AbbVie(2 entities) | 19 | $1,221 |
| Boehringer Ingelheim | 25 | $799 |
| Amarin Pharma, Inc. | 35 | $626 |
| AstraZeneca | 17 | $611 |
| Novo Nordisk | 15 | $563 |
| Pfizer | 11 | $389 |
| Amgen | 9 | $367 |
| Optinose US, Inc. | 12 | $349 |
| Novartis | 11 | $303 |
| Teva Pharmaceuticals USA, Inc. | 7 | $292 |
| GSK | 6 | $252 |
| Redhill Biopharma Inc. | 8 | $243 |
| Biohaven Pharmaceuticals, Inc. | 9 | $219 |
| Neurocrine Biosciences, Inc. | 3 | $210 |
| Merck | 6 | $128 |
| Phathom Pharmaceuticals, Inc. | 1 | $126 |
| Eisai Inc. | 6 | $115 |
| Bausch Health US, LLC | 4 | $111 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Kowa Pharmaceuticals America, Inc. | 7 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $56 |
| Johnson & Johnson | 3 | $56 |
| Exact Sciences | 2 | $56 |
| Astellas Pharma US Inc | 2 | $52 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Shield Therapeutics Inc | 1 | $29 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,143 in reported general payments places this provider in the 95th percentile of 12,963 general practice providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 11 | $1,806 |
| Atorvastatin Calcium | 56 | $347 |
| Amlodipine Besylate | 22 | $214 |
| Lisinopril | 44 | $185 |
| Montelukast Sodium | 12 | $184 |
| Metoprolol Succinate | 14 | $174 |
| Metformin Hcl | 42 | $141 |
| Losartan Potassium | 23 | $141 |
| Pantoprazole Sodium | 15 | $135 |
| Pravastatin Sodium | 22 | $108 |
| Simvastatin | 35 | $98 |
| Hydrochlorothiazide | 29 | $82 |
| Triamcinolone Acetonide | 12 | $54 |
| Ezetimibe | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other general practice in San Francisco
- Jared AdamsSan Francisco$862K
- Matthew YoungSan Francisco$127K
- Hessam AazamiCanoga Park$88.4M
- Frederic MollRedwood City$5.7M
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Bruce TorkanLos Angeles$3.8M
- Daniel JohnsonPalm Desert$1.5M
- Bradley ChingUpland$1.4M
- Marina GoldGlendale$784K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.